anastrozole has been researched along with levonorgestrel in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Barbara, G; Berlanda, N; Crosignani, PG; Fedele, L; Somigliana, E; Vercellini, P | 1 |
| Klein, S; Kraetzschmar, J; Nave, R; Rautenberg, T; Rohde, B; Schmitz, H; Schultze-Mosgau, MH; Waellnitz, K | 1 |
| Nave, R; Ploeger, BA; Reinecke, I; Schmitz, H; Schultze-Mosgau, MH | 1 |
| Chang, X; Höchel, J; Klein, S; Müller, A; Nave, R | 1 |
| Höchel, J; Klein, S; Mellinger, U; Nave, R; Schmitz, H | 1 |
| Acién, M; Acién, P; Velasco, I | 1 |
2 review(s) available for anastrozole and levonorgestrel
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Medical treatment for rectovaginal endometriosis: what is the evidence?
Topics: Anastrozole; Aromatase Inhibitors; Cohort Studies; Danazol; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Intrauterine Devices; Levonorgestrel; Nitriles; Pain; Patient Preference; Randomized Controlled Trials as Topic; Rectal Diseases; Treatment Outcome; Triazoles; Vaginal Diseases | 2009 |
5 trial(s) available for anastrozole and levonorgestrel
| Article | Year |
|---|---|
Pharmacokinetics, pharmacodynamics, safety and tolerability of an intravaginal ring releasing anastrozole and levonorgestrel in healthy premenopausal women: a Phase 1 randomized controlled trial.
Topics: Administration, Intravaginal; Adult; Anastrozole; Aromatase Inhibitors; Endometriosis; Estradiol; Female; Healthy Volunteers; Humans; Levonorgestrel; Nitriles; Ovarian Follicle; Premenopause; Triazoles; Women's Health; Young Adult | 2016 |
Model-Based Dose Selection for Intravaginal Ring Formulations Releasing Anastrozole and Levonorgestrel Intended for the Treatment of Endometriosis Symptoms.
Topics: Administration, Intravaginal; Adult; Anastrozole; Computer Simulation; Contraceptive Agents, Female; Drug Combinations; Drug Interactions; Endometriosis; Estradiol; Female; Humans; Levonorgestrel; Models, Biological; Nitriles; Ovarian Follicle; Sex Hormone-Binding Globulin; Triazoles; Young Adult | 2017 |
Absence of Effect of Intravaginal Miconazole, Clindamycin, Nonoxynol-9, and Tampons on the Pharmacokinetics of an Anastrozole/Levonorgestrel Intravaginal Ring.
Topics: Administration, Intravaginal; Adult; Anastrozole; Anti-Bacterial Agents; Antifungal Agents; Clindamycin; Contraceptives, Oral, Combined; Endometriosis; Female; Humans; Levonorgestrel; Menstrual Hygiene Products; Miconazole; Nitriles; Nonoxynol; Triazoles | 2018 |
Absence of Drug-Drug Interaction of Anastrozole on Levonorgestrel Delivered Simultaneously by an Intravaginal Ring: Results of a Phase 2 Trial.
Topics: Administration, Intravaginal; Adult; Anastrozole; Antineoplastic Agents, Hormonal; Contraceptive Agents, Hormonal; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Drug Interactions; Female; Humans; Levonorgestrel | 2019 |
Anastrozole and levonorgrestrel-releasing intrauterine device in the treatment of endometriosis: a randomized clinical trial.
Topics: Anastrozole; Contraceptive Agents, Female; Endometriosis; Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; London; Prospective Studies | 2021 |
3 other study(ies) available for anastrozole and levonorgestrel
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |